There is decreased risk for hospitalization in patients with heart failure who receive a high-dose inactivated influenza vaccine.

Real-world data supports the use of nirmatrelvir-ritonavir in reducing the risk for severe COVID-19 outcomes among nonhospitalized patients.

A novel color perimeter may serve as a potential tool to detect subtle visual changes dueto glucose dysfunction in preclinical diabetes.

Long COVID remains globally prevalent following COVID-19 infection, with a significant burden of symptoms lasting 1 to 2 years postinfection.

Since 2013, there has been an increase in the rate of physician attrition from clinical practice, according to a study.

In 2025, there was a greater than 50% rate of unfilled training positions in advanced heart failure and transplant cardiology.

The U.S. Food and Drug Administration (FDA) has approved Lasix ONYU (furosemide injection), a new drug-device combination developed by SQ Innovation, Inc., for treating edema caused by chronic heart ...

Left atrial appendage occlusion might be a treatment option for patients on dialysis with atrial fibrillation.

The addition of sotatercept, an activin-signaling inhibitor, to background therapy results in a lower risk for clinical worsening among adults with pulmonary arterial hypertension (PAH) who were ...

A review of emails between nurse liaisons and multisite researchers and nurses described the liaison’s essential role in communications across all participants. A review of emails between nurse ...

Risk for venous thromboembolism (VTE) after an operation for colorectal cancer (CRC) is higher among patients with inflammatory bowel disease (IBD), according to results of a population-based cohort ...

Use of ambient artificial intelligence (AI) scribes is associated with a reduction in burnout and cognitive task load among clinicians.